PNC Financial Services Group
TCRT icon

PNC Financial Services Group’s Alaunos Therapeutics TCRT Stock Holding History

PNC Financial Services Group’s Portfolio TCRT Stock Details TCRT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-1
Closed -$130 – 4818
2022
Q4 		$130 Buy
+1
New +$145 ﹤0.01% 4679
2022
Q3 		– Sell
-2
Closed – – 4610
2022
Q2 		$0 Sell
2
-7
-78% -$669 ﹤0.01% 4711
2022
Q1 		$0 Hold
9
– – ﹤0.01% 4698
2021
Q4 		$2K Sell
9
-129
-93% -$28.3K ﹤0.01% 4189
2021
Q3 		$37K Sell
138
-25
-15% -$7.64K ﹤0.01% 3237
2021
Q2 		$64K Buy
163
+129
+379% +$60.2K ﹤0.01% 2915
2021
Q1 		$18K Hold
34
– – ﹤0.01% 3451
2020
Q4 		$12K Hold
34
– – ﹤0.01% 3520
2020
Q3 		$12K Sell
34
-168
-83% -$74.2K ﹤0.01% 3452
2020
Q2 		$100K Sell
202
-100
-33% -$44.6K ﹤0.01% 2327
2020
Q1 		$112K Buy
302
+100
+50% +$51.7K ﹤0.01% 2151
2019
Q4 		$143K Hold
202
– – ﹤0.01% 2284
2019
Q3 		$130K Buy
202
+166
+461% +$132K ﹤0.01% 2394
2019
Q2 		$30K Hold
36
– – ﹤0.01% 3191
2019
Q1 		$21K Hold
36
– – ﹤0.01% 3348
2018
Q4 		$9K Sell
36
-704
-95% -$278K ﹤0.01% 3582
2018
Q3 		$356K Hold
740
– – ﹤0.01% 1864
2018
Q2 		$335K Sell
740
-3
-0.4% -$1.9K ﹤0.01% 1889
2018
Q1 		$437K Hold
743
– – ﹤0.01% 1702
2017
Q4 		$462K Hold
743
– – ﹤0.01% 1694
2017
Q3 		$685K Hold
743
– – ﹤0.01% 1455
2017
Q2 		$693K Hold
743
– – ﹤0.01% 1452
2017
Q1 		$706K Hold
743
– – ﹤0.01% 1442
2016
Q4 		$597K Hold
743
– – ﹤0.01% 1495
2016
Q3 		$628K Sell
743
-44
-6% -$35.4K ﹤0.01% 1451
2016
Q2 		$648K Buy
787
+3
+0.4% +$3.27K ﹤0.01% 1436
2016
Q1 		$872K Sell
784
-7
-0.9% -$7.16K ﹤0.01% 1307
2015
Q4 		$986K Sell
791
-6
-0.8% -$9.92K ﹤0.01% 1212
2015
Q3 		$1.08M Sell
797
-331
-29% -$546K ﹤0.01% 1199
2015
Q2 		$2.03M Buy
1,128
+162
+17% +$251K ﹤0.01% 973
2015
Q1 		$1.56M Buy
966
+160
+20% +$237K ﹤0.01% 1070
2014
Q4 		$614K Buy
806
+33
+4% +$17.5K ﹤0.01% 1443
2014
Q3 		$307K Buy
773
+60
+8% +$28.9K ﹤0.01% 1748
2014
Q2 		$431K Hold
713
– – ﹤0.01% 1517
2014
Q1 		$491K Buy
713
+2
+0.3% +$1.34K ﹤0.01% 1412
2013
Q4 		$462K Hold
711
– – ﹤0.01% 1431
2013
Q3 		$420K Hold
711
– – ﹤0.01% 1452
2013
Q2 		$224K Buy
+711
New +$197K ﹤0.01% 1718

Other funds holding TCRT

DCM
Discovery Capital Management South Norwalk, Connecticut $1.92B AUM 218.96% 1-Year Est. Return
MP
MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

PNC Financial Services Group's TCRT Position: Q1 2023 in Review

PNC Financial Services Group sold out of Alaunos Therapeutics (TCRT) in Q1 2023, closing a stake of 1 share — an estimated $130 sold.

PNC Financial Services Group first reported a position in TCRT in Q2 2013 and held it in 38 quarters. The position peaked at $2.03M in Q2 2015. 108 funds tracked by Wall St. Rank hold TCRT as of Q1 2023.

  • PNC Financial Services Group reported no remaining Alaunos Therapeutics position as of Q1 2023 after selling out during the quarter.
  • PNC Financial Services Group sold 1 Alaunos Therapeutics share in Q1 2023, an estimated $130.
  • PNC Financial Services Group first reported a position in Alaunos Therapeutics in Q2 2013 and held it in 38 quarters.
  • PNC Financial Services Group's Alaunos Therapeutics position peaked at $2.03M in Q2 2015.
  • 108 funds tracked by Wall St. Rank held Alaunos Therapeutics as of Q1 2023.

Based on PNC Financial Services Group's 13F filing for Q1 2023, filed 15 May 2023.